Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000038809
JPRN-UMIN000038809CompletedPhase 1

Phase I trial of ADR-002K for patients with ischemic cardiomyopathy who undergo coronary artery bypass surgery - Phase I trial of ADR-002K for patients with ischemic cardiomyopathy who undergo coronary artery bypass surgery

Osaka University Hospital0 sites6 target enrollmentStarted: December 6, 2019Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
6
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1) Patients who have a combination of cardiovascular disease such as severe organic valvular disease or aortic aneurysm determined by investigator or co-investigator to affect clinical trial procedure 2) Patients whose participation in a clinical trial is considered inappropriate at the discretion of the investigator or co-investigator 3) Others

Investigators

Similar Trials

Active, not recruiting
Phase 1
Phase I trial of ADR-002K for patients with ischemic cardiomyopathy who undergo coronary artery bypass surgeryIschemic cardiomyopathy undergoing coronary artery bypass surgeryCoronary artery bypass, ischemic cardiomyopathy, adipose-derived mesenchymal stem cellsD017202
JPRN-jRCT2053190103SAWA Yoshiki6
Recruiting
Phase 2
A Phase 2 Study of ADR-001 in Patients with Severe Pneumonia caused by SARS-CoV-2 infectioPatients with Severe Pneumonia caused by SARS-CoV-2 infection
JPRN-jRCT2053210023Okawa Sumito20
Active, not recruiting
Phase 2
ADR-001-N1Compensated liver cirrhosis (Child-Pugh A)
JPRN-jRCT2033210425Terai Shuji9
Recruiting
Not Applicable
Phase 1b/2 trial for CKD-702 in combination with irinotecan as a third-line therapy for gastric cancer with MET or EGFR protein overexpressioNeoplasms
KCT0008025ational Cancer Center52
Active, not recruiting
Not Applicable
A randomized clinical study of stem cells taken from fat tissue in the experimental treatment of patients with myocardial infarction (heart attack)patients with ST-elevation myocardial infarction after PCI with stentMedDRA version: 14.1Level: LLTClassification code 10028597Term: Myocardial infarction acuteSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2010-022153-42-DECytori Therapeutics, Inc216